Fig. 4
From: Omentin-1 inhibits the development of benign prostatic hyperplasia by attenuating local inflammation
Omentin-1 effectively attenuates testosterone propionate-induced BPH. A Representative immunofluorescence images showing the expression of GFP in BPH-1 cells after intervention of Ad-Itln-1. Scale bar: 100 μm. B, C Expression of ITLN-1 protein in prostate samples detected by western blot (B) and relative abundance of ITLN-1 in prostate samples (C). D, E Representative fluorescence images and relative fluorescence intensity of prostate tissue after tail vein injection of Ad-GFP or Ad-Itln-1. Scale bar: 200 μm. n = 3, one-way ANOVA. F–I body weight at end point (F), gross anatomy of prostate tissues (G), prostate weight (H), and prostate index (I) of the mice after indicated different treatments. n = 8, one-way ANOVA. J Serum levels of PAP of the mice after indicated different treatments. n = 6, one-way ANOVA. The values of the individual statistical significances and statistical comparisons were indicated in the figure